Brief: 3Sbio Says Unit And Syncromune To Develop And Commercialize Sunshine Guojian's Anti-Pd-1 Antibody 609A

3SBio

04/01/2022 13:42

Jan 4 (Reuters) - 3SBio Inc  1530.HK :
    * UNIT AND SYNCROMUNE TO DEVELOP AND COMMERCIALIZE SUNSHINE
GUOJIAN'S ANTI-PD-1 ANTIBODY 609A


Further company coverage:  1530.HK 

 ((Reuters.Briefs@thomsonreuters.com;))